I strongly believe that parents must be included as key partners in the care of their children, and that the best results are obtained when all members of the family feel informed and respected.


Undergraduate Degree

  • University of Alberta , 2000 , Edmonton, Alberta , Canada

Graduate Degree

  • University of Toronto , 2001 , Toronto , Canada

Medical School

  • University of Alberta , 2005 , Edmonton, Alberta , Canada


  • Stollery Children's Hospital , 2009 , Edmonton, Alberta , Canada


Pediatric Cardiology
  • Boston Children's Hospital , 2012 , Boston , MA


Interventional Cardiology
  • Boston Children's Hospital , 2013 , Boston , MA

Philosophy of Care

It is a tremendous privilege to care for children with heart disease. I continually strive to be worthy of the trust parents place in me, whether the setting is the clinic, the intensive care unit, or the catheterization laboratory. I strongly believe that parents must be included as key partners in the care of their children, and that the best results are obtained when all members of the family feel informed and respected.


Dr. Esch completed graduate studies in mathematics at the University of Toronto before entering medical school at the University of Alberta (Edmonton, Canada). He completed his pediatrics residency at Stollery Children’s Hospital, where he also served as chief resident. He came to Boston Children’s Hospital (and the US) as a pediatric cardiology fellow and stayed for a senior fellowship in pediatric interventional cardiology. As staff in the interventional cardiology division, his clinical interests include invasive assessment and management of congenital heart disease and pulmonary hypertension. Dr. Esch also has interests in general outpatient cardiology (with an emphasis on immigrant and marginalized populations), and runs a weekly pediatric cardiology clinic at Boston Medical Center. His research interests include the development of new percutaneous strategies for the management of severe pulmonary hypertension, invasive assessment of right heart hemodynamics, and adverse events in pediatric congenital catheterization.


  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Pediatric Cardiology


Publications powered by Harvard Catalyst Profiles

  1. Modified AngioVac System use With Extracorporeal Membrane Oxygenation in a Child With Fontan Thrombosis. ASAIO J. 2021 May 07. View abstract
  2. Apixaban for treatment of intracardiac thrombosis in children with congenital heart disease. Interact Cardiovasc Thorac Surg. 2020 06 01; 30(6):950-951. View abstract
  3. A geometrically adaptable heart valve replacement. Sci Transl Med. 2020 02 19; 12(531). View abstract
  4. Value of Troponin Testing for Detection of Heart Disease in Previously Healthy Children. J Am Heart Assoc. 2020 02 18; 9(4):e012897. View abstract
  5. A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy. JACC Basic Transl Sci. 2019 Dec; 4(8):871-888. View abstract
  6. Systemic Sirolimus to Prevent In-Stent Stenosis in Pediatric Pulmonary Vein Stenosis. Pediatr Cardiol. 2020 Feb; 41(2):282-289. View abstract
  7. Pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals: collateral vessel disease burden and unifocalisation strategies. Cardiol Young. 2018 Sep; 28(9):1091-1098. View abstract
  8. Hemodynamic parameters predict adverse outcomes following biventricular conversion with single-ventricle palliation takedown. J Thorac Cardiovasc Surg. 2017 08; 154(2):572-582. View abstract
  9. Mechanism of valve failure and efficacy of reintervention through catheterization in patients with bioprosthetic valves in the pulmonary position. Ann Pediatr Cardiol. 2017 Jan-Apr; 10(1):11-17. View abstract
  10. Noninvasive Cardiac Output Estimation by Inert Gas Rebreathing in Mechanically Ventilated Pediatric Patients. J Pediatr. 2016 10; 177:184-190.e3. View abstract
  11. Systemic rapamycin to prevent in-stent stenosis in peripheral pulmonary arterial disease: early clinical experience. Cardiol Young. 2016 Oct; 26(7):1319-26. View abstract
  12. Acute kidney injury after Fontan completion: Risk factors and outcomes. J Thorac Cardiovasc Surg. 2015 Jul; 150(1):190-7. View abstract
  13. Systemic Embolic Complications of Pulmonary Vein Angioplasty in Children. Pediatr Cardiol. 2015 Oct; 36(7):1357-62. View abstract
  14. Transcatheter brachial fistula creation for treatment of pulmonary arteriovenous malformations. Catheter Cardiovasc Interv. 2014 Apr 01; 83(5):768-73. View abstract
  15. Acute outcomes after introduction of a standardized clinical assessment and management plan (SCAMP) for balloon aortic valvuloplasty in congenital aortic stenosis. Congenit Heart Dis. 2014 Jul-Aug; 9(4):316-25. View abstract
  16. Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv. 2013 Jun; 6(3):301-10. View abstract
  17. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. J Heart Lung Transplant. 2013 Apr; 32(4):381-7. View abstract
  18. Radiofrequency-assisted transseptal perforation for electrophysiology procedures in children and adults with repaired congenital heart disease. Pacing Clin Electrophysiol. 2013 May; 36(5):607-11. View abstract
  19. Wire-related pulmonary artery injury during pediatric and adult congenital interventional cardiac catheterization. Congenit Heart Dis. 2013 Jul-Aug; 8(4):296-301. View abstract
  20. Differential hemodynamic effects of levosimendan in a porcine model of neonatal hypoxia-reoxygenation. Neonatology. 2012; 101(3):192-200. View abstract
  21. Torsades de Pointes ventricular tachycardia in a pediatric patient treated with fluconazole. Pediatr Cardiol. 2008 Jan; 29(1):210-3. View abstract